ARCA Biopharma Inc (ABIO)

NASDAQ
2.460
-0.040(-1.59%)
  • Volume:
    7,140
  • Day's Range:
    2.447 - 2.530
  • 52 wk Range:
    1.710 - 3.840

ABIO Overview

Prev. Close
2.5
Day's Range
2.447-2.53
Revenue
-
Open
2.49
52 wk Range
1.71-3.84
EPS
-1.28
Volume
7,140
Market Cap
36.03M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
114,568
P/E Ratio
-
Beta
2.11
1-Year Change
-30.94%
Shares Outstanding
14,410,143
Next Earnings Date
Aug 04, 2022
What is your sentiment on ARCA Biopharma?
or
Vote to see community's results!

ARCA Biopharma Inc News

ARCA Biopharma Inc Analysis

ARCA Biopharma Inc Company Profile

ARCA Biopharma Inc Company Profile

Employees
18

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company, which is focused on development and commercialization of targeted therapies for cardiovascular diseases. The Company's lead product includes Recombinant Nematode Anticoagulant Protein c2, or rNAPc2 (AB201) and Gencaro (bucindolol hydrochloride). rNAPc2 (AB201) is a treatment for diseases caused by ribonucleic acid (RNA), viruses, focusing on COVID-19, the disease syndrome caused by the SARS-CoV-2 virus. The gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties for the treatment of atrial fibrillation (AF) in patients with heart failure. The Company is conducting Phase II b clinical trial of rNAPc2 (AB201). Its ASPEN-COVID-19 Phase IIb is a randomized, multi-center, international clinical trial evaluating two dose regimens of rNAPc2 versus heparin prescribed per local standard of care in hospitalized SARS-CoV-2 positive patients that also have an elevated D-dimer level.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellNeutralBuySell
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellSellStrong BuyStrong Sell
  • go go go
    0
    • From now it will go up
      0
      • 2nd quarter it will hit over 15
        0
        • looks like that isn't right
          0
        • Ο
          0
      • Any one see 13G/A filing from two firms increased shares???
        0
        • I'm in at the bottom only way to go is up
          0
          • I bought mines when it was $13. Lost hundreds so far. I doubt this ever goes up again
            1
            • time to buy again?
              0
              • buy 6-7$ and run up to 9.75$
                0
                • Why is this dropping ??
                  0
                  • Would you take profit if you made up to 300%
                    0
                  • I see 😪
                    0
                  • buy at 7.5. target price 78
                    0
                • This may drop to 10 Monday morning.
                  0